389 related articles for article (PubMed ID: 34957267)
1. Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases.
Li L; Hu Z; Xiong Y; Yao Y
Front Cardiovasc Med; 2021; 8():803984. PubMed ID: 34957267
[TBL] [Abstract][Full Text] [Related]
2. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
[TBL] [Abstract][Full Text] [Related]
3. Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension.
Zuern CS; Eick C; Rizas KD; Bauer S; Langer H; Gawaz M; Bauer A
J Am Coll Cardiol; 2013 Dec; 62(22):2124-30. PubMed ID: 23973686
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
5. Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.
Linz D; Hohl M; Elliott AD; Lau DH; Mahfoud F; Esler MD; Sanders P; Böhm M
Clin Auton Res; 2018 Aug; 28(4):375-384. PubMed ID: 29429026
[TBL] [Abstract][Full Text] [Related]
6. Is renal denervation still a treatment option in cardiovascular disease?
Hoogerwaard AF; Elvan A
Trends Cardiovasc Med; 2020 May; 30(4):189-195. PubMed ID: 31147257
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches: targeting sympathetic outflow in the carotid sinus.
Hering D; Narkiewicz K
Blood Press; 2023 Dec; 32(1):2232873. PubMed ID: 37470450
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.
Zhou L; Zhang J; Jiang XM; Xie DJ; Wang JS; Li L; Li B; Wang ZM; Rothman AMK; Lawrie A; Chen SL
JACC Cardiovasc Interv; 2015 Dec; 8(15):2013-2023. PubMed ID: 26738673
[TBL] [Abstract][Full Text] [Related]
9. Device-based approaches for renal nerve ablation for hypertension and beyond.
Thorp AA; Schlaich MP
Front Physiol; 2015; 6():193. PubMed ID: 26217232
[TBL] [Abstract][Full Text] [Related]
10. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.
Hoogerwaard AF; de Jong MR; Elvan A
Curr Hypertens Rep; 2018 Mar; 20(3):24. PubMed ID: 29556850
[TBL] [Abstract][Full Text] [Related]
11. Renal Artery Denervation for Hypertension.
Ranard LS; Swaminathan RV
Curr Treat Options Cardiovasc Med; 2019 Feb; 21(2):7. PubMed ID: 30762119
[TBL] [Abstract][Full Text] [Related]
12. Renal Sympathetic Denervation Improves Outcomes in a Canine Myocardial Infarction Model.
Nasi-Er BG; Lou X; Zhang Y; Sun H; Zhou X; Li Y; Zhou Q; Zhang J; Tang B; Lu Y
Med Sci Monit; 2019 May; 25():3887-3893. PubMed ID: 31127792
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
[TBL] [Abstract][Full Text] [Related]
14. Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings.
Huang B; Scherlag BJ; Yu L; Lu Z; He B; Jiang H
Clin Res Cardiol; 2015 Jul; 104(7):535-43. PubMed ID: 25596725
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure.
Booth LC; Schlaich MP; Nishi EE; Yao ST; Xu J; Ramchandra R; Lambert GW; May CN
Int J Cardiol; 2015; 190():220-6. PubMed ID: 25920032
[TBL] [Abstract][Full Text] [Related]
16. Device-Based Neuromodulation for Resistant Hypertension Therapy.
Lohmeier TE; Hall JE
Circ Res; 2019 Mar; 124(7):1071-1093. PubMed ID: 30920919
[TBL] [Abstract][Full Text] [Related]
17. Current status of pulmonary artery denervation.
Davies MG; Miserlis D; Hart JP
Front Cardiovasc Med; 2022; 9():972256. PubMed ID: 36262207
[TBL] [Abstract][Full Text] [Related]
18. The human sympathetic nervous system: its relevance in hypertension and heart failure.
Parati G; Esler M
Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
[TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.
Fengler K; Rommel KP; Okon T; Schuler G; Lurz P
World J Cardiol; 2016 Aug; 8(8):436-46. PubMed ID: 27621771
[TBL] [Abstract][Full Text] [Related]
20. Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.
Hong MN; Li XD; Chen DR; Ruan CC; Xu JZ; Chen J; Wu YJ; Ma Y; Zhu DL; Gao PJ
Oncotarget; 2016 Oct; 7(42):67828-67840. PubMed ID: 27661131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
